Aprogen, which raised investors’ expectations by announcing acquiring a drug manufacturing facility in the U. S., has reversed the announcement and abandoned its acquisition.“In these times of global business slump, we thought the investment risk would increase sharply and decided not to push for th
Inventage Lab is inviting gossip in the market by releasing news material different from facts about its clinical trials of new drug candidates.On Monday, the company, a microfluidics-based drug developer, distributed a news release headlined, “Applying for phase 1 clinical trial in Australia for lo
Global biopharmaceutical companies focus on Asia as the hub of their clinical trials to develop mRNA vaccines, and Korea has been chosen by none.BioNTech, which developed the Covid-19 vaccine, Comirnaty, said Monday that it would set up a clinical trial hub in Taiwan. The German company plans to spe
Shares of Helixmith plunged Friday after the biotech firm announced that CanariaBio M will acquire the company.According to Helixmith on Thursday, the company agreed to transfer management rights to CanariaBio M, the parent company of CanariaBio. CanariaBio M has decided to pay 35 billion won ($27.2
LegoChem Bioscience said it had transferred its antibody-drug conjugate (ADC) platform technology to Amgen in a deal worth 1.6 trillion won ($1.2 billion).Under the accord, Amgen will have the global development and commercialization rights for five targeted ADC therapies by utilizing its own antibo
Bioindustry analyst experts predicted that mergers and acquisitions (M&A) will play a central role next for the bioindustry at a seminar on bioindustry trends on Tuesday hosted by KoreaBIO, an association of local biotech firms.The seminar took a look at the global healthcare growth opportunities in
A study that vindicates the relationship between desmoid tumors and TGF (transforming growth factor)-beta signal transmission has been published in an international journal.MedPacto stressed that the study reaffirmed the possibility of Vactosertib, a TGF-beta inhibitor, as a treatment for the desmoi
Researchers in Korea said they proved that long-term exposure to fine dust increases the risk of cancer cell metastasis through increased heparin-binding EGF-like growth factor (HBEGF) expression in macrophages.A report from the Energy Policy Institute at the University of Chicago (EPIC) states that
Lotte Biologics said it decided to reduce the scale of a paid-in capital increase, originally planned to finance the acquisition of Bristol-Myers Squibb (BMS)'s Syracuse plant in the U.S.According to Lotte Biologics' revised disclosure on Thursday, the paid-in capital increase will be reduced from 3
RIGHT Foundation held a briefing session on Thursday to explain the eligibility criteria for two ongoing project grants and share about 2023 co-funding projects.Accordingly, the Product Development Award (PDA) is targeted at companies or research institutions developing vaccines, treatments, and dia
Korea is home to a rapidly growing bioindustry; nothing showed this better than the Bioindustry Networking event hosted by KoreaBio Tuesday, which drew keen attention from the Swiss, U.S., U.K., Canadian, and Vietnamese embassies in Korea.The who’s who of the local bio industry attended the event as
PharmAbcine, a Korean antibody treatment developer, said it would collaborate with the U.S. Merck (known as MSD outside North America) to develop PMC-309, a “VISTA (V-domain Ig suppressor of T cell activation) antibody, for a phase 1 study.PMC-309 will be tested for its safety and efficacy in advanc
Ambassadors, government officials and public health experts in the vaccine field across the Indo-Pacific region gathered at a forum in Seoul to share lessons and strategies for strengthening resilience and preparedness against future pandemics at Lotte Hotel on Wednesday.The 2nd Vaccine Cooperation
The tuberculosis (TB) workshop, entitled "Re-imagine TB Care," highlighted domestic and global TB challenges and how to leverage Korea’s strength in R&D and health technologies to improve access to TB prevention, diagnosis, treatment, and care in TB-affected countries in Seoul on Friday.The workshop
An Australian delegate comprised of bio-officials spanning research, academia, and industry, recently visited Korea to discuss partnerships with domestic biotech companies.At a meeting between the delegates and Korean biotech companies on Tuesday evening, Korea Biomedical Review sat down with two of
Middle-aged women with high diastolic blood pressure are 1.7 times likelier to develop breast cancer, so they need to be more careful with their usual BP control, a study said Wednesday.Hypertension and breast cancer are two of the most prevalent chronic diseases globally. Moreover, according to the
Celltrion said Monday it proved the effectiveness and safety of RemsimaSC (pipeline name: CT-P13 SC), an autoimmune disease treatment, in two global phase 3 trials. RemsimaSC is a subcutaneous injection (SC) form of infliximab, widely used in TNF-α inhibitor market. It is the world’s first inflixima
A team of researchers at Seoul National University Hospital together with the National Cancer Control Institute published a study that revealed brain damage from long-term air pollution exposure.Ambient air pollution is one of the most important global health issues and Korea is frequently affected
Lilly Korea said on Monday that its CDK 4&6 inhibitor Verzenio (ingredient: abemaciclib) has been approved by the Ministry of Food and Drug Safety (MFDS) on Friday for an additional indication for high-risk early breast cancer.Specifically, it was approved for hospital patients with a high risk of r
Celltrion has won new “domestic” approval for a Humira (adalimumab) biosimilar with the same dosage and formulation as the currently marketed product, drawing the industry’s attention to the reason.According to the Ministry of Food and Drug Safety, Celltrion obtained domestic approval for Yuflyma Pe